Lv2
160 积分 2022-04-11 加入
Discovery of FLT3-ITD Inhibitor Clifutinib: A Novel Biphenylacetylene Urea Derivative in Clinical Trials for the Treatment of Relapsed/Refractory FLT3-ITD+ Acute Myeloid Leukemia
17天前
已完结
Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
24天前
已完结
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations
28天前
已完结
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years
1个月前
已完结
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
3个月前
已完结
Recent progress in ITP treatment
3个月前
已完结
BTK inhibitors: past, present, and future
3个月前
已完结
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
3个月前
已完结
Risk of bleeding associated with BTK inhibitor monotherapy: a systematic review and meta-analysis of randomized controlled trials
3个月前
已完结
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
4个月前
已完结
皖公网安备34019202002308
